Enanta Pharmaceuticals, Inc.

Organization

Watertown, MA, US

Ticker Symbols

NASDAQ:ENTA

PHARMACEUTICAL PREPARATIONS
Business Address
500 ARSENAL STREET WATERTOWN MA 02472 617 607 0800
Mailing Address
500 ARSENAL STREET WATERTOWN MA 02472
State Location
MA
State of Incorporation
DE

Organizations

Please log in for detailed analytics

Patents Grantslast 30 patents

Information Patent Grant
Antiviral compounds
- Patent number 12,162,857
- Issue date Dec 10, 2024
- Enanta Pharmaceuticals, Inc.
- Jianming Yu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Spiropyrrolidine derived antiviral agents
- Patent number 12,145,942
- Issue date Nov 19, 2024
- Enanta Pharmaceuticals, Inc.
- Hui Cao
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Heterocyclic antiviral agents
- Patent number 12,145,941
- Issue date Nov 19, 2024
- Enanta Pharmaceuticals, Inc.
- Joseph D. Panarese
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Hepatitis B antiviral agents
- Patent number 12,054,493
- Issue date Aug 6, 2024
- Enanta Pharmaceuticals, Inc.
- Yao-Ling Qiu
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Apoptosis signal-regulating kinase 1 inhibitors and methods of use...
- Patent number 12,018,017
- Issue date Jun 25, 2024
- Enanta Pharmaceuticals, Inc.
- Guoqiang Wang
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Hepatitis B antiviral agents
- Patent number 12,011,425
- Issue date Jun 18, 2024
- Enanta Pharmaceuticals, Inc.
- Yao-Ling Qiu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antiviral heterocyclic compounds
- Patent number 12,006,326
- Issue date Jun 11, 2024
- Enanta Pharmaceuticals, Inc.
- Adam Szymaniak
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Processes for the preparation of 4,6,7-trifluoro-1H-indole-2-carbox...
- Patent number 12,006,291
- Issue date Jun 11, 2024
- Enanta Pharmaceuticals, Inc.
- Kaicheng Zhu
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Saturated spirocyclics as antiviral agents
- Patent number 11,993,600
- Issue date May 28, 2024
- Enanta Pharmaceuticals, Inc.
- Joseph D. Panarese
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Spiropyrrolidine derived antiviral agents
- Patent number 11,976,084
- Issue date May 7, 2024
- Enanta Pharmaceuticals, Inc.
- Guoqiang Wang
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Macrocyclic antiviral agents
- Patent number 11,970,502
- Issue date Apr 30, 2024
- Enanta Pharmaceuticals, Inc.
- Jiajun Zhang
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Bile acid derivatives as FXR/TGR5 agonists and methods of use thereof
- Patent number 11,958,879
- Issue date Apr 16, 2024
- Enanta Pharmaceuticals, Inc.
- Guoqiang Wang
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Benzodiazepine derivatives as RSV inhibitors
- Patent number 11,952,389
- Issue date Apr 9, 2024
- Enanta Pharmaceuticals, Inc.
- Brian C. Shook
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antiviral heterocyclic compounds
- Patent number 11,945,830
- Issue date Apr 2, 2024
- Enanta Pharmaceuticals, Inc.
- Adam Szymaniak
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Heterocyclic compounds as anti-viral agents
- Patent number 11,945,824
- Issue date Apr 2, 2024
- Enanta Pharmaceuticals, Inc.
- Yat Sun Or
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Spiropyrrolidine derived antiviral agents
- Patent number 11,919,910
- Issue date Mar 5, 2024
- Enanta Pharmaceuticals, Inc.
- Guoqiang Wang
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Spiropyrrolidine derived antiviral agents
- Patent number 11,912,714
- Issue date Feb 27, 2024
- Enanta Pharmaceuticals, Inc.
- Hui Cao
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Benzodiazepine derivatives as RSV inhibitors
- Patent number 11,912,695
- Issue date Feb 27, 2024
- Enanta Pharmaceuticals, Inc.
- Kaicheng Zhu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Functionalized heterocycles as antiviral agents
- Patent number 11,891,393
- Issue date Feb 6, 2024
- Enanta Pharmaceuticals, Inc.
- Joseph Panarese
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Alkyne-containing antiviral agents
- Patent number 11,858,945
- Issue date Jan 2, 2024
- Enanta Pharmaceuticals, Inc.
- Joseph D. Panarese
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Tetrazole containing apoptosis signal-regulating kinase 1 inhibitor...
- Patent number 11,834,436
- Issue date Dec 5, 2023
- Enanta Pharmaceuticals, Inc.
- Guoqiang Wang
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Hepatitis B antiviral agents
- Patent number 11,760,755
- Issue date Sep 19, 2023
- Enanta Pharmaceuticals, Inc.
- Yao-Ling Qiu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Substituted heterocycles as antiviral agents
- Patent number 11,738,019
- Issue date Aug 29, 2023
- Enanta Pharmaceuticals, Inc.
- Joseph Panarese
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Bile acid derivatives as FXR/TGR5 agonists and methods of use thereof
- Patent number 11,718,641
- Issue date Aug 8, 2023
- Enanta Pharmaceuticals, Inc.
- Guoqiang Wang
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Hepatitis B antiviral agents
- Patent number 11,596,611
- Issue date Mar 7, 2023
- Enanta Pharmaceuticals, Inc.
- Yao-Ling Qiu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Tetrazole derivatives of bile acids as FXR/TGR5 agonists and method...
- Patent number 11,578,097
- Issue date Feb 14, 2023
- Enanta Pharmaceuticals, Inc.
- Yat Sun Or
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Antiviral heterocyclic compounds
- Patent number 11,572,367
- Issue date Feb 7, 2023
- Enanta Pharmaceuticals, Inc.
- Adam Szymaniak
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Apoptosis signal-regulating kinase 1 inhibitors and methods of use...
- Patent number 11,560,368
- Issue date Jan 24, 2023
- Enanta Pharmaceuticals, Inc.
- Guoqiang Wang
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Isoxazole derivatives as FXR agonists and methods of use thereof
- Patent number 11,555,032
- Issue date Jan 17, 2023
- Enanta Pharmaceuticals, Inc.
- Guoqiang Wang
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Dihydroquinoxaline and dihydropyridopyrazine derivatives as RSV inh...
- Patent number 11,534,439
- Issue date Dec 27, 2022
- Enanta Pharmaceuticals, Inc.
- Jianming Yu
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
Apoptosis Signal-Regulating Kinase 1 Inhibitors and Methods of Use...
- Publication number 20240376079
- Publication date Nov 14, 2024
- Enanta Pharmaceuticals, Inc.
- Guoqiang Wang
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Antiviral Heterocyclic Compounds
- Publication number 20240368176
- Publication date Nov 7, 2024
- Enanta Pharmaceuticals, Inc.
- Adam SZYMANIAK
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Fused Heterobicyclic Antiviral Agents
- Publication number 20240368096
- Publication date Nov 7, 2024
- Enanta Pharmaceuticals, Inc.
- Samuel BARTLETT
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Hepatitis B Antiviral Agents
- Publication number 20240366538
- Publication date Nov 7, 2024
- Enanta Pharmaceuticals, Inc.
- Yao-Ling Qiu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Antiviral Heterocyclic Compounds
- Publication number 20240368174
- Publication date Nov 7, 2024
- Enanta Pharmaceuticals, Inc.
- Adam Szymaniak
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BENZODIAZEPINE DERIVATIVES AS RSV INHIBITORS
- Publication number 20240360117
- Publication date Oct 31, 2024
- Enanta Pharmaceuticals, Inc.
- Kaicheng Zhu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Benzodiazepine Derivatives as RSV Inhibitors
- Publication number 20240360155
- Publication date Oct 31, 2024
- Enanta Pharmaceuticals, Inc.
- Brian C. Shook
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Covalent Inhibitors As Antiviral Agents
- Publication number 20240327334
- Publication date Oct 3, 2024
- Enanta Pharmaceuticals, Inc.
- Xuri GAO
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Fused Heterotetracyclic Antiviral Agents
- Publication number 20240325409
- Publication date Oct 3, 2024
- Enanta Pharmaceuticals, Inc.
- Sean RAFFERTY
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Bile Acid Derivatives as FXR/TGR5 Agonists and Methods of Use Thereof
- Publication number 20240327452
- Publication date Oct 3, 2024
- Enanta Pharmaceuticals, Inc.
- Guoqiang Wang
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Functionalized Heterocycles as Antiviral Agents
- Publication number 20240262828
- Publication date Aug 8, 2024
- Enanta Pharmaceuticals, Inc.
- Joseph D. PANARESE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TETRAZOLE CONTAINING APOPTOSIS SIGNAL-REGULATING KINASE 1 INHIBITOR...
- Publication number 20240228464
- Publication date Jul 11, 2024
- Enanta Pharmaceuticals, Inc.
- Guoqiang Wang
- C07 - ORGANIC CHEMISTRY
Information Patent Application
MACROCYCLIC CHALCONE-AMIDE DERIVED ANTIVIRAL AGENTS
- Publication number 20240207224
- Publication date Jun 27, 2024
- Enanta Pharmaceuticals, Inc.
- Jiajun Zhang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BILE ACID DERIVATIVES AS FXR/TGR5 AGONISTS AND METHODS OF USE THEREOF
- Publication number 20240140984
- Publication date May 2, 2024
- Enanta Pharmaceuticals, Inc.
- Guoqiang Wang
- C07 - ORGANIC CHEMISTRY
Information Patent Application
FUSED HETEROBICYCLIC ANTIVIRAL AGENTS
- Publication number 20240140922
- Publication date May 2, 2024
- Enanta Pharmaceuticals, Inc.
- Samuel Bartlett
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TETRAZOLE CONTAINING APOPTOSIS SIGNAL-REGULATING KINASE 1 INHIBITOR...
- Publication number 20240132476
- Publication date Apr 25, 2024
- Enanta Pharmaceuticals, Inc.
- Guoqiang Wang
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CRYSTAL FORMS OF AN ANTI-SARS COV-2 AGENT
- Publication number 20240132512
- Publication date Apr 25, 2024
- Enanta Pharmaceuticals, Inc.
- Kaicheng Zhu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PYRIMIDINONE-CONTAINING 17-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1...
- Publication number 20230416268
- Publication date Dec 28, 2023
- Enanta Pharmaceuticals, Inc.
- Yat Sun Or
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTIVIRAL COMPOUNDS
- Publication number 20230365525
- Publication date Nov 16, 2023
- Enanta Pharmaceuticals, Inc.
- Jianming Yu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIVIRAL HETEROCYCLIC COMPOUNDS
- Publication number 20230357258
- Publication date Nov 9, 2023
- Enanta Pharmaceuticals, Inc.
- Adam Szymaniak
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
NOVEL SPIROPYRROLIDINE DERIVED ANTIVIRAL AGENTS
- Publication number 20230331734
- Publication date Oct 19, 2023
- Enanta Pharmaceuticals, Inc.
- Hui Cao
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PROCESSES FOR THE PREPARATION OF SUBSTITUTED SPIROOXINDOLE DERIVATIVES
- Publication number 20230295175
- Publication date Sep 21, 2023
- Enanta Pharmaceuticals, Inc.
- Kaicheng Zhu
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HEPATITIS B ANTIVIRAL AGENTS
- Publication number 20230241012
- Publication date Aug 3, 2023
- Enanta Pharmaceuticals, Inc.
- Yao-Ling Qiu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PROCESSES FOR THE PREPARATION OF 4,6,7-TRIFLUORO-1H-INDOLE-2-CARBOX...
- Publication number 20230234922
- Publication date Jul 27, 2023
- Enanta Pharmaceuticals, Inc.
- Kaicheng Zhu
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SPIROPYRROLIDINE DERIVED ANTIVIRAL AGENTS
- Publication number 20230203048
- Publication date Jun 29, 2023
- Enanta Pharmaceuticals, Inc.
- Guoqiang Wang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HETEROCYCLIC ANTIVIRAL AGENTS
- Publication number 20230174542
- Publication date Jun 8, 2023
- Enanta Pharmaceuticals, Inc.
- Joseph D. Panarese
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SATURATED SPIROCYCLICS AS ANTIVIRAL AGENTS
- Publication number 20230174531
- Publication date Jun 8, 2023
- Enanta Pharmaceuticals, Inc.
- Joseph D. Panarese
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
APOPTOSIS SIGNAL-REGULATING KINASE 1 INHIBITORS AND METHODS OF USE...
- Publication number 20230174515
- Publication date Jun 8, 2023
- Enanta Pharmaceuticals, Inc.
- Guoqiang Wang
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ALKYNE-CONTAINING ANTIVIRAL AGENTS
- Publication number 20230159545
- Publication date May 25, 2023
- Enanta Pharmaceuticals, Inc.
- Joseph D. Panarese
- C07 - ORGANIC CHEMISTRY
Information Patent Application
NOVEL SPIROPYRROLIDINE DERIVED ANTIVIRAL AGENTS
- Publication number 20230159546
- Publication date May 25, 2023
- Enanta Pharmaceuticals, Inc.
- Jorden Kass
- C07 - ORGANIC CHEMISTRY

Trademarklast 30 trademarks

Information Trademark
97277880 - GREAT CHEMISTRY CURES
- Serial number 97277880
- Filing date Feb 22, 2022
- Enanta Pharmaceuticals, Inc.
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
97248094
- Serial number 97248094
- Filing date Feb 1, 2022
- Enanta Pharmaceuticals, Inc.
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
97248087 - ENANTA PHARMACEUTICALS
- Serial number 97248087
- Filing date Feb 1, 2022
- Enanta Pharmaceuticals, Inc.
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
78137400 - ENANTA PHARMACEUTICALS
- Serial number 78137400
- Registration number 2875563
- Filing date Jun 20, 2002
- Enanta Pharmaceuticals, Inc.
- 42 - Scientific and technological services and research and design relating thereto
Information Trademark
75883929 - ENANTA PHARMACEUTICALS
- Serial number 75883929
- Registration number 2776014
- Filing date Dec 30, 1999
- Enanta Pharmaceuticals, Inc.
- 42 - Scientific and technological services and research and design relating thereto
Information Trademark
75718427 - PEPTIDE MORPHING
- Serial number 75718427
- Registration number 2500784
- Filing date Jun 1, 1999
- Enanta Pharmaceuticals, Inc.
- 42 - Scientific and technological services and research and design relating thereto

Enanta Pharmaceuticals, Inc.

Organization

Ticker Symbols

Business Address

Mailing Address

State Location

State of Incorporation

Patents Grantslast 30 patents

Antiviral compounds

Spiropyrrolidine derived antiviral agents

Heterocyclic antiviral agents

Hepatitis B antiviral agents

Apoptosis signal-regulating kinase 1 inhibitors and methods of use...

Hepatitis B antiviral agents

Antiviral heterocyclic compounds

Processes for the preparation of 4,6,7-trifluoro-1H-indole-2-carbox...

Saturated spirocyclics as antiviral agents

Spiropyrrolidine derived antiviral agents

Macrocyclic antiviral agents

Bile acid derivatives as FXR/TGR5 agonists and methods of use thereof

Benzodiazepine derivatives as RSV inhibitors

Antiviral heterocyclic compounds

Heterocyclic compounds as anti-viral agents

Spiropyrrolidine derived antiviral agents

Spiropyrrolidine derived antiviral agents

Benzodiazepine derivatives as RSV inhibitors

Functionalized heterocycles as antiviral agents

Alkyne-containing antiviral agents

Tetrazole containing apoptosis signal-regulating kinase 1 inhibitor...

Hepatitis B antiviral agents

Substituted heterocycles as antiviral agents

Bile acid derivatives as FXR/TGR5 agonists and methods of use thereof

Hepatitis B antiviral agents

Tetrazole derivatives of bile acids as FXR/TGR5 agonists and method...

Antiviral heterocyclic compounds

Apoptosis signal-regulating kinase 1 inhibitors and methods of use...

Isoxazole derivatives as FXR agonists and methods of use thereof

Dihydroquinoxaline and dihydropyridopyrazine derivatives as RSV inh...

Patents Applicationslast 30 patents

Apoptosis Signal-Regulating Kinase 1 Inhibitors and Methods of Use...

Antiviral Heterocyclic Compounds

Fused Heterobicyclic Antiviral Agents

Hepatitis B Antiviral Agents

Antiviral Heterocyclic Compounds

BENZODIAZEPINE DERIVATIVES AS RSV INHIBITORS

Benzodiazepine Derivatives as RSV Inhibitors

Covalent Inhibitors As Antiviral Agents

Fused Heterotetracyclic Antiviral Agents

Bile Acid Derivatives as FXR/TGR5 Agonists and Methods of Use Thereof

Functionalized Heterocycles as Antiviral Agents

TETRAZOLE CONTAINING APOPTOSIS SIGNAL-REGULATING KINASE 1 INHIBITOR...

MACROCYCLIC CHALCONE-AMIDE DERIVED ANTIVIRAL AGENTS

BILE ACID DERIVATIVES AS FXR/TGR5 AGONISTS AND METHODS OF USE THEREOF

FUSED HETEROBICYCLIC ANTIVIRAL AGENTS

TETRAZOLE CONTAINING APOPTOSIS SIGNAL-REGULATING KINASE 1 INHIBITOR...

CRYSTAL FORMS OF AN ANTI-SARS COV-2 AGENT

PYRIMIDINONE-CONTAINING 17-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1...

ANTIVIRAL COMPOUNDS

ANTIVIRAL HETEROCYCLIC COMPOUNDS

NOVEL SPIROPYRROLIDINE DERIVED ANTIVIRAL AGENTS

PROCESSES FOR THE PREPARATION OF SUBSTITUTED SPIROOXINDOLE DERIVATIVES

HEPATITIS B ANTIVIRAL AGENTS

PROCESSES FOR THE PREPARATION OF 4,6,7-TRIFLUORO-1H-INDOLE-2-CARBOX...

SPIROPYRROLIDINE DERIVED ANTIVIRAL AGENTS

HETEROCYCLIC ANTIVIRAL AGENTS

SATURATED SPIROCYCLICS AS ANTIVIRAL AGENTS

APOPTOSIS SIGNAL-REGULATING KINASE 1 INHIBITORS AND METHODS OF USE...

ALKYNE-CONTAINING ANTIVIRAL AGENTS

NOVEL SPIROPYRROLIDINE DERIVED ANTIVIRAL AGENTS

Trademarklast 30 trademarks

97277880 - GREAT CHEMISTRY CURES

97248094

97248087 - ENANTA PHARMACEUTICALS

78137400 - ENANTA PHARMACEUTICALS

75883929 - ENANTA PHARMACEUTICALS

75718427 - PEPTIDE MORPHING